skip to main content
US FlagAn official website of the United States government
dot gov icon
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
https lock icon
Secure .gov websites use HTTPS
A lock ( lock ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Explore Research Products in the PAR
It may take a few hours for recently added research products to appear in PAR search results.


Title: Nanotechnologies for Physiology-Informed Drug Delivery to the Lymphatic System
Accompanying the increasing translational impact of immunotherapeutic strategies to treat and prevent disease has been a broadening interest across both bioscience and bioengineering in the lymphatic system. Herein, the lymphatic system physiology, ranging from its tissue structures to immune functions and effects, is described. Design principles and engineering approaches to analyze and manipulate this tissue system in nanoparticle-based drug delivery applications are also elaborated.  more » « less
Award ID(s):
2047017
PAR ID:
10478318
Author(s) / Creator(s):
; ; ;
Publisher / Repository:
Annual Review of Biomedical Engineering
Date Published:
Journal Name:
Annual Review of Biomedical Engineering
Volume:
25
Issue:
1
ISSN:
1523-9829
Page Range / eLocation ID:
233 to 256
Format(s):
Medium: X
Sponsoring Org:
National Science Foundation
More Like this
  1. ; ; ; ; (, Advanced Healthcare Materials)
    Abstract Secondary lymphedema is a life‐long disorder characterized by chronic tissue swelling and inflammation that obstruct interstitial fluid circulation and immune cell trafficking. Regenerating lymphatic vasculatures using various strategies represents a promising treatment for lymphedema. Growth factor injection and gene delivery have been developed to stimulate lymphangiogenesis and augment interstitial fluid resorption. Using bioengineered materials as growth factor delivery vehicles allows for a more precisely targeted lymphangiogenic activation within the injured site. The implantation of prevascularized lymphatic tissue also promotesin situlymphatic capillary network formation. The engineering of larger scale lymphatic tissues, including lymphatic collecting vessels and lymph nodes constructed by bioengineered scaffolds or decellularized animal tissues, offers alternatives to reconnecting damaged lymphatic vessels and restoring lymph circulation. These approaches provide lymphatic vascular grafting materials to reimpose lymphatic continuity across the site of injury, without creating secondary injuries at donor sites. The present work reviews molecular mechanisms mediating lymphatic system development, approaches to promoting lymphatic network regeneration, and strategies for engineering lymphatic tissues, including lymphatic capillaries, collecting vessels, and nodes. Challenges of advanced translational applications are also discussed. 
    more » « less
  2. ; (, Advanced Biology)
    Abstract Fibrosis occurs in many chronic diseases with lymphatic vascular insufficiency (e.g., kidney disease, tumors, and lymphedema). New lymphatic capillary growth can be triggered by fibrosis‐related tissue stiffening and soluble factors, but questions remain for how related biomechanical, biophysical, and biochemical cues affect lymphatic vascular growth and function. The current preclinical standard for studying lymphatics is animal modeling, but in vitro and in vivo outcomes often do not align. In vitro models can also be limited in their ability to separate vascular growth and function as individual outcomes, and fibrosis is not traditionally included in model design. Tissue engineering provides an opportunity to address in vitro limitations and mimic microenvironmental features that impact lymphatic vasculature. This review discusses fibrosis‐related lymphatic vascular growth and function in disease and the current state of in vitro lymphatic vascular models while highlighting relevant knowledge gaps. Additional insights into the future of in vitro lymphatic vascular models demonstrate how prioritizing fibrosis alongside lymphatics will help capture the complexity and dynamics of lymphatics in disease. Overall, this review aims to emphasize that an advanced understanding of lymphatics within a fibrotic disease—enabled through more accurate preclinical modeling—will significantly impact therapeutic development toward restoring lymphatic vessel growth and function in patients. 
    more » « less
  3. ; ; ; ; ; ; ; (, Advanced Materials Interfaces)
    Abstract Granular hydrogels show great promise in biomedical applications by mimicking the extracellular matrix and fostering a supportive microenvironment for tissue regeneration. This study investigates how tuning granular hydrogel properties influences lymphatic tube formation. Microgels were fabricated using norbornene‐modified hyaluronic acid (NorHA) via pipetting or vortexing for 90 s (V90s) and 180 s (V180s), then assembled into granular hydrogels under loose and tight packing conditions. These conditions produced gels with varied pore morphologies and bulk rheological properties. Lymphatic capillary formation occurred only in tightly packed gels, where mechanical properties converged, highlighting the importance of gel morphology over stiffness. V180s samples showed earlier vessel formation as seen in lymphatic gene and protein expression, while pipetted gels exhibited greater capillary connectivity, forming larger vessel clusters and fewer small satellite structures. The pipetting gels also supported lower‐curvature, more linear capillary networks that bridged multiple droplets, likely due to reduced entrapment in large voids compared to vortexed gels. These findings suggest that in bulk granular gels, lymphatic tube formation is governed not by mechanical stiffness but by pore size and gel topology (periodicity). Understanding and optimizing these morphological parameters can inform future strategies in lymphatic tissue engineering and regenerative medicine. 
    more » « less
  4. ; ; ; ; (, Cells Tissues Organs)
    Introduction: Generating new lymphatic vessels has been postulated as an innovative therapeutic strategy for various disease phenotypes, including neurodegenerative diseases, metabolic syndrome, cardiovascular disease, and lymphedema. Yet, compared to the blood vascular system, protocols to differentiate human induced pluripotent stem cells (hiPSCs) into lymphatic endothelial cells (LECs) are still lacking. Methods: Transcription factors, ETS2 and ETV2 are key regulators of embryonic vascular development, including lymphatic specification. While ETV2 has been shown to efficiently generate blood endothelial cells, little is known about ETS2 and its role in lymphatic differentiation. Here, we describe a method for rapid and efficient generation of LECs using transcription factors, ETS2 and ETV2. Results: This approach reproducibly differentiates four diverse hiPSCs into LECs with exceedingly high efficiency. Timely activation of ETS2 was critical, to enable its interaction with Prox1, a master lymphatic regulator. Differentiated LECs express key lymphatic markers, VEGFR3, LYVE-1, and Podoplanin, in comparable levels to mature LECs. The differentiated LECs are able to assemble into stable lymphatic vascular networks in vitro, and secrete key lymphangiocrine, reelin. Conclusion: Overall, our protocol has broad applications for basic study of lymphatic biology, as well as toward various approaches in lymphatic regeneration and personalized medicine. 
    more » « less
  5. ; ; (, International Conference on Swarm Intelligence)
    The lymphatic system is a networked structure used by billions of immune cells, including T cells and Dendritic cells, to locate and identify invading pathogens. Dendritic cells carry pieces of pathogens to the nearest lymph node, and T cells travel through the lymphatic vessels and search within lymph nodes to find them. Here we investigate how the topology of the lymphatic network affects the time for this search to be completed. Building on prior work that maps out the human lymphatic network, we develop and extend a method to infer the lymphatic network topology of mice. We compare search times for the modeled and observed topologies and show that they are similar to each other and consistent with observed immune response times. This is relevant for translating immune response times in mice, where most experimental work occurs, into expected immune response times in humans. Our analysis predicts that for large systemic infections, the topology of the lymphatic network allows immune response times to remain fast even as animal mass increases by orders of magnitude. This work advances our understanding of how the structure of the lymphatic network supports the swarm intelligence of the immune system. It also elucidates general principles relating swarm size and organization to search speed. 
    more » « less
  • Citation Formats
  • MLA
  • APA
  • Chicago
  • BibTeX
  • Save / Share this Record
  • Send to Email